000 | 01916 a2200541 4500 | ||
---|---|---|---|
005 | 20250516035427.0 | ||
264 | 0 | _c20120321 | |
008 | 201203s 0 0 eng d | ||
022 | _a1573-4978 | ||
024 | 7 |
_a10.1007/s11033-011-0720-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeo, Gwi-Moon | |
245 | 0 | 0 |
_aA self-contained enzyme activating prodrug cytotherapy for preclinical melanoma. _h[electronic resource] |
260 |
_bMolecular biology reports _cJan 2012 |
||
300 |
_a157-65 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
650 | 0 | 4 |
_aCarboxylesterase _xmetabolism |
650 | 0 | 4 |
_aCell Transplantation _xmethods |
650 | 0 | 4 |
_aDNA Primers _xgenetics |
650 | 0 | 4 |
_aDrug Carriers _xmetabolism |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGenes, Transgenic, Suicide _xgenetics |
650 | 0 | 4 | _aIrinotecan |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMagnetics |
650 | 0 | 4 |
_aMelanoma _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMonocyte-Macrophage Precursor Cells _xmetabolism |
650 | 0 | 4 | _aNanoparticles |
650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
700 | 1 | _aRachakatla, Raja Shekar | |
700 | 1 | _aBalivada, Sivasai | |
700 | 1 | _aPyle, Marla | |
700 | 1 | _aShrestha, Tej B | |
700 | 1 | _aBasel, Matthew T | |
700 | 1 | _aMyers, Carl | |
700 | 1 | _aWang, Hongwang | |
700 | 1 | _aTamura, Masaaki | |
700 | 1 | _aBossmann, Stefan H | |
700 | 1 | _aTroyer, Deryl L | |
773 | 0 |
_tMolecular biology reports _gvol. 39 _gno. 1 _gp. 157-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11033-011-0720-7 _zAvailable from publisher's website |
999 |
_c20830045 _d20830045 |